Clinical Trial

Mutations and Phenotypes of Unclassifiable Inherited Bone Marrow Failure Syndromes

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated July 1, 2022 (before its estimated January 2024 completion). Its status may not reflect the trial's current state.
Summary
Inherited bone marrow failure syndromes (IBMFSs) are a diverse collection of genetic illnesses characterized by various degrees of peripheral cytopenias due to defective single-lineage or multi-lineage hematopoiesis, it can manifest itself at birth or later in life.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2022-06-23.
Trial Details
NCT Number NCT05436587
Lead Sponsor Sohag University
Collaborators: Kyoto University, Assiut University
Conditions Inherited BMF Syndrome
Enrollment 250 participants
Start Date 2022-01-10
Primary Completion 2024-01 (estimated)
Study Completion 2028-01 (estimated)
Updated on ClinicalTrials.gov 2022-07-01